表紙
市場調查報告書

組織再生材料:醫療設備管道評估,2020年

Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 949875
出版日期 內容資訊 英文 63 Pages
訂單完成後即時交付
價格
組織再生材料:醫療設備管道評估,2020年 Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年07月01日內容資訊: 英文 63 Pages
簡介

該報告提供了有關組織再生材料(這是一種可促進牙周硬組織和軟組織丟失的生物材料的再生)的生物材料的全面信息,以及對產品在各個開發階段和進展中的比較分析。提供有關正在進行的臨床試驗的信息。

調查範圍

  • 目前正在開發的各種組織再生材料
  • 有關主要管道產品的詳細信息,包括產品概述,許可和開發合作詳細信息。
  • 參與組織再生材料開發的主要公司和管道項目
  • 從開發的早期階段到批准/□□銷售階段的各個開發階段的管道產品信息
  • 管道產品的主要臨床試驗數據
  • 細分/行業的最新趨勢

為什麼要購買

  • 從競爭對手那裡獲取重要的信息,分析和見解,以幫助改進您的研發策略。
  • 確定具有強大產品組合的初創企業,並製定有效的應對策略以確保競爭優勢。
  • 瞭解當前正在開發的重要組織再生材料。
  • 您可以製定市場進入策略和市場擴展策略。
  • 找到最有前途的關鍵公司,並製定有效的合併/收購計劃。
  • 您可以收集有關各種產品的當前開發階段,地區和計劃推出日期的詳細信息。

內容

第1章內容

  • 表列表
  • 圖形列表

第2章簡介

  • 組織再生材料概述

第3章開發中的產品

  • 按開發階段劃分的管道產品
  • 分地區的管道產品
  • 按批准程序階段劃分的管道產品
  • 按批准日期劃分的管道產品
  • 當前的臨床試驗

第4章正在開發的管道產品

  • 各公司發展階段的管道產品

第5章主要公司和產品概述

  • Biora AB
  • Collagen Matrix Inc
  • Colorado Therapeutics、LLC
  • credentis AG
  • Gene Techno Science Co Ltd
  • Histocell SL
  • Indian Institute of Technology Bombay
  • LaunchPad Medical、LLC
  • Maxigen Biotech Inc
  • Nobel Biocare Services AG
  • Novatissue SAS
  • Orthocell Ltd
  • Polytechnic University of Catalonia
  • Straumann Holding AG
  • SurgaColl Technologies Ltd
  • SweetBio、Inc.
  • Tigran Technologies AB
  • Trimph Technology Pty Ltd

第6章組織再生材料行業的最新趨勢

第7章附錄

  • 調查方法
  • 關於全球數據

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0929EPD

GlobalData's Medical Devices sector report, "Tissue Regenerative Materials - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Tissue Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Tissue Regenerative Materials is a biomaterial component which facilitates regeneration of lost periodontal hard and soft tissue.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Regenerative Materials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Regenerative Materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Tissue Regenerative Materials Overview

3 Products under Development

  • 3.1 Tissue Regenerative Materials - Pipeline Products by Stage of Development
  • 3.2 Tissue Regenerative Materials - Pipeline Products by Territory
  • 3.3 Tissue Regenerative Materials - Pipeline Products by Regulatory Path
  • 3.4 Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
  • 3.5 Tissue Regenerative Materials - Ongoing Clinical Trials

4 Tissue Regenerative Materials - Pipeline Products under Development by Companies

  • 4.1 Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
  • 4.2 Tissue Regenerative Materials - Pipeline Products by Stage of Development

5 Tissue Regenerative Materials Companies and Product Overview

  • 5.1 Biora AB Company Overview
    • 5.1.1 Biora AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Collagen Matrix Inc Company Overview
    • 5.2.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Colorado Therapeutics, LLC Company Overview
    • 5.3.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 credentis AG Company Overview
    • 5.4.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Gene Techno Science Co Ltd Company Overview
    • 5.5.1 Gene Techno Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Histocell SL Company Overview
    • 5.6.1 Histocell SL Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Indian Institute of Technology Bombay Company Overview
    • 5.7.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 LaunchPad Medical, LLC Company Overview
    • 5.8.1 LaunchPad Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Maxigen Biotech Inc Company Overview
    • 5.9.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.1 Nobel Biocare Services AG Company Overview
    • 5.10.1 Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Novatissue SAS Company Overview
    • 5.11.1 Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Orthocell Ltd Company Overview
    • 5.12.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Polytechnic University of Catalonia Company Overview
    • 5.13.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Straumann Holding AG Company Overview
    • 5.14.1 Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 SurgaColl Technologies Ltd Company Overview
    • 5.15.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 SweetBio, Inc. Company Overview
    • 5.16.1 SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Tigran Technologies AB Company Overview
    • 5.17.1 Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Trimph Technology Pty Ltd Company Overview
    • 5.18.1 Trimph Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Tissue Regenerative Materials- Recent Developments

  • 6.1 Feb 18, 2020: Straumann finishes 2019 with solid Q4, as full-year organic revenue climbs 17% and core EBIT margin expands to 27.1%
  • 6.2 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement
  • 6.3 Feb 10, 2020: CollPlant announces appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
  • 6.4 Feb 05, 2020: Orthocell receives new patents for CelGro platform
  • 6.5 Feb 03, 2020: Mark Johnson joins Straumann's Executive Management as Head of Research, Development & Operations, succeeding Dr Gerhard Bauer, who is retiring after a distinguished career with the Group
  • 6.6 Dec 06, 2019: Straumann Group strengthens emphasis on orthodontics and digital transformation
  • 6.7 Nov 29, 2019: CollPlant reports third quarter 2019 financial results and provides business update
  • 6.8 Oct 22, 2019: CollPlant CEO Yehiel Tal appointed to serve on international society for Biofabrication's Industry Relations Committee
  • 6.9 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update
  • 6.1 Aug 29, 2019: Straumann Group announces two appointments to its Executive Management team
  • 6.11 Aug 14, 2019: Straumann Group: Strong momentum continues as first-half organic revenue climbs 16% and core EBIT margin reaches 28%

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us

List of Tables

List of Tables

  • Table 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development
  • Table 2: Tissue Regenerative Materials - Pipeline Products by Territory
  • Table 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path
  • Table 4

List of Figures

List of Figures

  • Figure 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development
  • Figure 2: Tissue Regenerative Materials - Pipeline Products by Territory
  • Figure 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path
  • Figure 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
  • Figure 5: Tissue Regenerative Materials - Ongoing Clinical Trials